Genetically engineered T cells with PTPN2 knockout have improved functionality and anti-tumor activity
US-12553030-B2 · Feb 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Patent family 80933487
This patent family groups 2 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 80933487 |
| Family type | — |
| Earliest priority | Mar 9, 2021 |
| First filing country | US |
| Member publications | 2 |
| Countries | US |
| Representative publication | US12553030B2 — Genetically engineered T cells with PTPN2 knockout have improved functionality and anti-tumor activity |
Representative publication
Best representative member for this family based on priority and filing country.
US12553030B2 — Genetically engineered T cells with PTPN2 knockout have improved functionality and anti-tumor activity (published Feb 17, 2026)
Member publications
Related publications in this family.